Moderna COVID-19 Vaccine
The Advisory Committee on Immunization Practices will be meeting to discuss recommendations for the recently authorized Moderna COVID-19 Vaccine for ages 6-17 years on June 23rd. The Interim Clinical Considerations and associated materials for healthcare providers will be updated with applicable guidance soon after that meeting.
Adverse events that occur in a recipient after COVID-19 vaccination are required to be reported to the Vaccine Adverse Event Reporting System (VAERS). FDA requires vaccination providers to report vaccine administration errors, serious adverse events, cases of multisystem inflammatory syndrome, and cases of COVID-19 that result in hospitalization or death after administration of COVID-19 vaccine under an EUA. Reporting is encouraged for other clinically significant adverse events, even if it is not clear that a vaccine caused the adverse event. Complete and submit reports to VAERS online.
For further assistance with reporting to VAERS, call 1-800-822-7967.